Notably, CELSR2 mRNA expression was significantly higher in Grade 2, Grade 3 and recurrent Grade 4 gliomas when compared to the normal control group (Fig. 1C, Supplementary Fig. 1A). The gene discussed is CELSR2; the disease is central nervous system cancer.